MLchartDataset catalogue

Patent · US10138448B2 · B2 · US

Deactivation wipe kit

(11) Publication number
US10138448B2
(21) Application number
15/271,957
(22) Filing date
2016-09-21
(30) Priority date
2016-04-11
(43) Publication date
2018-11-27
(45) Date of grant
2018-11-27
(51) IPC
A62D 3/38; A61L 2/18; B65B 5/04; B65B 51/10; B65B 55/08; B65B 7/02; B65D 30/24; B65D 75/58; B65D 81/22; C11D 17/04; A62D 3/36
(52) CPC
  • C11D Detergent compositions; use of single substances as detergents; soap or soap-making; resin soaps; recovery of glycerol: 17/049, 7/10, 7/261
  • A61L Methods or apparatus for sterilising materials or objects in general; disinfection, sterilisation or deodorisation of air; chemical aspects of bandages, dressings, absorbent pads or surgical articles; materials for bandages, dressings, absorbent pads or surgical articles: 2/08, 2/18, 2101/06, 2101/20, 2101/34, 2202/121, 2202/17
  • B65B Machines, apparatus or devices for, or methods of, packaging articles or materials; unpacking: 2210/06, 5/045, 51/10, 55/027, 55/08, 7/02
  • B65D Containers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers; accessories, closures, or fittings therefor; packaging elements; packages: 31/14, 31/145, 33/00, 75/28, 75/5805, 81/22
(73) Assignee
Veltek Associates Inc
(72) Inventors
Mark J. Compo; Michael BALESTRI
(54) Title
Deactivation wipe kit
(57) Abstract

A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be used in a clean room to deactivate most hazardous drugs on a work surface.

Full text
View on Google Patents

Claims (13)

  1. A hazardous drug deactivation wipe kit, comprising: a first pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a wipe saturated in hypochlorite solution, wherein the one-way filling valve is configured to permit the hypochlorite solution to be filled into the first pouch while preventing the hypochlorite solution to escape the first pouch; a second pouch containing a wipe saturated in thiosulfate solution; and a third pouch containing a wipe saturated in isopropyl alcohol solution, wherein the deactivation wipe kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface.
  2. The deactivation wipe kit of claim 1, wherein the hypochlorite solution is a 5.25% sodium hypochlorite solution.
  3. The deactivation wipe kit of claim 1, wherein the thiosulfate solution is a 2% sodium thiosulfate solution.
  4. The deactivation wipe kit of claim 1, wherein the isopropyl alcohol solution is a 70% isopropyl alcohol solution.
  5. The deactivation wipe kit of claim 1, wherein the wipe in the first pouch is formed of 100% polypropylene.
  6. The deactivation wipe kit of any of claim 1, wherein the wipe in the second pouch and the wipe in the third pouch is formed of 100% polyester.
  7. The deactivation wipe kit of any of claim 1, wherein each of the first pouch, the second pouch, and the third pouch are formed of a multi-layered structure comprised of coated polyester, low density polyethylene, aluminum foil, hydroxypropylcellulose, linear low density polyethylene, or combinations thereof.
  8. The deactivation wipe kit of claim 1, wherein each of the first pouch, the second pouch, and the third pouch comprise a perforation adjacent to an end thereof.
  9. The deactivation wipe kit of any of claim 1, wherein the one-way valve is configured to permit the first pouch to be filled with the hypochlorite solution after the wipe has already been sealed in the first pouch.
  10. A deactivation wipe kit, comprising: a first closed pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a wipe saturated in first solution, wherein the one-way filling valve is configured to permit the first solution to be filled into the first pouch while preventing the first solution to escape the first pouch; and a second closed pouch containing a wipe saturated in second solution.
  11. The kit of claim 10, further comprising a third pouch containing a wipe saturated in third solution.
  12. The kit of claim 11, wherein the first solution comprises sterile hypochlorite, the second solution comprises thiosulfate, and the third solution comprises isopropyl alcohol.
  13. The kit of claim 10, wherein the kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface.

Description

The invention relates to a wipe kit used for deactivation, decontamination, and disinfection or cleaning in a clean room environment and a method of preparing and using the same.

A clean environment or controlled environment is a space designed, maintained, and controlled to prevent particle and microbiological contamination of products. Clean environments include clean rooms and clean workspaces (such as hooded workspaces), which are collectively referred to here as a clean room. Clean rooms are most commonly designed for use in manufacturing facilities and medical research and treatment facilities in the pharmaceutical, biotechnology, and healthcare industries, to name a few. Sterile clean room environments may be classified under a variety of classification schemes, including the International Organization of Standardization (“ISO”) Cleanroom Standards, whereby the highest level of sterilization is an ISO 1 clean room and a normal ambient air environment (no sterilization) is classified as ISO 9.

Certain chemical compositions are used inside clean rooms including, for instance, germicidal disinfectants such as phenols, cleaners, quaternary ammonium, peracetic acid, as well as various sporicides, such as peracetic acid, bleach, and hydrogen peroxide. The disinfectants and sporicides are used in clean rooms to disinfect clean room surfaces. In certain clean room environments, such as those in the healthcare industry, surfaces can become exposed to certain hazardous drugs.

Citations (16)

  • US3625351A
  • US3930041A
  • US5811113A
  • US7066354B2
  • US20050221113A1
  • US8080216B2
  • FR2876358A1
  • US8162137B2
  • US20090238502A1
  • US20150336788A1
  • US20120269459A1
  • US20130095058A1
  • US9108208B2
  • US20140033655A1
  • US20150101287A1
  • US20150125502A1
Record as JSON
{
  "publication_number": "US10138448B2",
  "country": "US",
  "kind": "B2",
  "title": "Deactivation wipe kit",
  "abstract": "A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be used in a clean room to deactivate most hazardous drugs on a work surface.",
  "claims": [
    "1. A hazardous drug deactivation wipe kit, comprising: a first pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a wipe saturated in hypochlorite solution, wherein the one-way filling valve is configured to permit the hypochlorite solution to be filled into the first pouch while preventing the hypochlorite solution to escape the first pouch; a second pouch containing a wipe saturated in thiosulfate solution; and a third pouch containing a wipe saturated in isopropyl alcohol solution, wherein the deactivation wipe kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface.",
    "2. The deactivation wipe kit of claim 1, wherein the hypochlorite solution is a 5.25% sodium hypochlorite solution.",
    "3. The deactivation wipe kit of claim 1, wherein the thiosulfate solution is a 2% sodium thiosulfate solution.",
    "4. The deactivation wipe kit of claim 1, wherein the isopropyl alcohol solution is a 70% isopropyl alcohol solution.",
    "5. The deactivation wipe kit of claim 1, wherein the wipe in the first pouch is formed of 100% polypropylene.",
    "6. The deactivation wipe kit of any of claim 1, wherein the wipe in the second pouch and the wipe in the third pouch is formed of 100% polyester.",
    "7. The deactivation wipe kit of any of claim 1, wherein each of the first pouch, the second pouch, and the third pouch are formed of a multi-layered structure comprised of coated polyester, low density polyethylene, aluminum foil, hydroxypropylcellulose, linear low density polyethylene, or combinations thereof.",
    "8. The deactivation wipe kit of claim 1, wherein each of the first pouch, the second pouch, and the third pouch comprise a perforation adjacent to an end thereof.",
    "9. The deactivation wipe kit of any of claim 1, wherein the one-way valve is configured to permit the first pouch to be filled with the hypochlorite solution after the wipe has already been sealed in the first pouch.",
    "10. A deactivation wipe kit, comprising: a first closed pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a wipe saturated in first solution, wherein the one-way filling valve is configured to permit the first solution to be filled into the first pouch while preventing the first solution to escape the first pouch; and a second closed pouch containing a wipe saturated in second solution.",
    "11. The kit of claim 10, further comprising a third pouch containing a wipe saturated in third solution.",
    "12. The kit of claim 11, wherein the first solution comprises sterile hypochlorite, the second solution comprises thiosulfate, and the third solution comprises isopropyl alcohol.",
    "13. The kit of claim 10, wherein the kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface."
  ],
  "description_excerpt": "The invention relates to a wipe kit used for deactivation, decontamination, and disinfection or cleaning in a clean room environment and a method of preparing and using the same.\n\nA clean environment or controlled environment is a space designed, maintained, and controlled to prevent particle and microbiological contamination of products. Clean environments include clean rooms and clean workspaces (such as hooded workspaces), which are collectively referred to here as a clean room. Clean rooms are most commonly designed for use in manufacturing facilities and medical research and treatment facilities in the pharmaceutical, biotechnology, and healthcare industries, to name a few. Sterile clean room environments may be classified under a variety of classification schemes, including the International Organization of Standardization (“ISO”) Cleanroom Standards, whereby the highest level of sterilization is an ISO 1 clean room and a normal ambient air environment (no sterilization) is classified as ISO 9.\n\nCertain chemical compositions are used inside clean rooms including, for instance, germicidal disinfectants such as phenols, cleaners, quaternary ammonium, peracetic acid, as well as various sporicides, such as peracetic acid, bleach, and hydrogen peroxide. The disinfectants and sporicides are used in clean rooms to disinfect clean room surfaces. In certain clean room environments, such as those in the healthcare industry, surfaces can become exposed to certain hazardous drugs.",
  "cpc": [
    "C11D 17/049",
    "A61L 2/08",
    "A61L 2/18",
    "A61L 2101/06",
    "A61L 2101/20",
    "A61L 2101/34",
    "A61L 2202/121",
    "A61L 2202/17",
    "B65B 2210/06",
    "B65B 5/045",
    "B65B 51/10",
    "B65B 55/027",
    "B65B 55/08",
    "B65B 7/02",
    "B65D 31/14",
    "B65D 31/145",
    "B65D 33/00",
    "B65D 75/28",
    "B65D 75/5805",
    "B65D 81/22",
    "C11D 7/10",
    "C11D 7/261"
  ],
  "ipc": [
    "A62D 3/38",
    "A61L 2/18",
    "B65B 5/04",
    "B65B 51/10",
    "B65B 55/08",
    "B65B 7/02",
    "B65D 30/24",
    "B65D 75/58",
    "B65D 81/22",
    "C11D 17/04",
    "A62D 3/36"
  ],
  "assignees": [
    "Veltek Associates Inc"
  ],
  "inventors": [
    "Mark J. Compo",
    "Michael BALESTRI"
  ],
  "filing_date": "2016-09-21",
  "publication_date": "2018-11-27",
  "grant_date": "2018-11-27",
  "priority_date": "2016-04-11",
  "application_number": "US-201615271957-A",
  "family_id": "59999199",
  "cited_by_count": 10,
  "citations": [
    "US3625351A",
    "US3930041A",
    "US5811113A",
    "US7066354B2",
    "US20050221113A1",
    "US8080216B2",
    "FR2876358A1",
    "US8162137B2",
    "US20090238502A1",
    "US20150336788A1",
    "US20120269459A1",
    "US20130095058A1",
    "US9108208B2",
    "US20140033655A1",
    "US20150101287A1",
    "US20150125502A1"
  ]
}

Record 3,157 of 8,000 in Patents full text (MLC-0201). Request the full dataset.